Stepping Stones Group | AI Transformation Index
Stepping Stones Group is a structurally durable healthcare services business: IDEA mandates, professional licensing requirements, and embedded school distr...

Overview
The Stepping Stones Group provides therapeutic and behavioral health services (ABA, speech therapy, occupational therapy) to children with special needs and autism, primarily through school-based and home/community settings, generating revenue on a fee-for-service basis from school districts, families, and insurers.
Executive Summary
Stepping Stones Group is a structurally durable healthcare services business: IDEA mandates, professional licensing requirements, and embedded school district relationships create real barriers to AI-native disruption, and the core clinical product requires licensed human practitioners regardless of AI capability advances. The AI opportunity is meaningful but operationally scoped — the biggest value is in clinical workflow efficiency (documentation, scheduling, compliance) that frees therapist time for billable care, not in transforming the business model. For Leonard Green, the strategic implication is that AI is a margin and capacity improvement story here, not a platform transformation story — and the company's small engineering team means outside catalysis would be needed to realize even those operational gains.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
61.5
Ciridae AI Score
Durability Rationale
Stepping Stones Group is structurally durable because the core paid outcome — in-person therapeutic intervention for children with special needs — cannot be replicated by AI alone. IDEA mandates, state licensing requirements for BCBAs, SLPs, and OTs, and deep trust requirements from families and school districts create a multi-layered regulatory and physical moat that AI-native entrants cannot bypass. The primary durability risk is not AI substitution of the clinical product but competitive fragmentation: the market is fragmented, switching costs are moderate rather than high, and scale advantages are real but not decisive in a services business that competes clinician-by-clinician at the district level.
Opportunity Rationale
The AI opportunity for SSG is real but bounded by the physical nature of the core service — the session with the child cannot be automated. The clearest and most impactful AI play is clinical workflow compression: AI-assisted documentation, progress note generation, treatment plan drafting, and scheduling optimization could meaningfully recapture clinician time and improve billable utilization, which is the central economic lever in this model. The transformation upside is moderate — throughput per clinician improves, but the business doesn't become a fundamentally different entity because the licensed human body remains the irreducible input; SSG cannot 10x output the way an insurance TPA or medical review company can by deploying AI on cognitive workflows at scale.
Key Risks
Durability risk: Medicaid/insurance reimbursement rate compression or IDEA funding rollbacks could undermine the payer structure that anchors this market, while a competitor deploying AI-driven documentation and scheduling tools at scale could offer equivalent clinical quality at lower cost, gradually eroding SSG's pricing power in a fragmented market where switching costs are moderate.
Opportunity risk: The licensed clinician supply constraint that makes AI workflow efficiency valuable also means throughput gains are capped — you cannot serve children without BCBAs, SLPs, and OTs, and AI cannot generate more licensed practitioners. If the binding constraint is clinician recruitment rather than clinician productivity, the opportunity for AI to transform economics is more limited than the workflow analysis suggests.
Company Overview
| Headquarters | Boston, Massachusetts, United States |
| Products / Services | Therapeutic and behavioral health services for children with Autism Spectrum Disorder (ASD), developmental delays, and behavioral challenges. School-based multidisciplinary services. Clinical support and mentorship for employees. Services delivered in home, school, community, and clinic settings. Telepractice and other innovative service delivery methods. |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
Acquisition of Gallagher Pediatric Therapy March 7, 2025 | Acquisition of Gallagher Pediatric Therapy, a California-based occupational and physical therapy provider. The Stepping Stones Group is backed by Leonard Green & Partners at this time. No specific senior Leonard Green individuals were named in the acquisition announcement. |
Acquired by Leonard Green & Partners December 1, 2021 | Leonard Green & Partners acquired Stepping Stones Group, a healthcare services company providing therapeutic behavioral health services to public school districts and private learning centers, from Five Arrows Capital Partners. This transaction marked Leonard Green & Partners' 9th healthcare services sector deal and 90th U.S. transaction. Stepping Stones Group is based in Lafayette, Colorado. |
Acquisition of Behavioral Learning Center (BLC) November 15, 2021 | Acquisition of Behavioral Learning Center (BLC), a California-based autism services provider. BLC co-founders Jody Stiegemeyer and Danielle Sheehy continued as executive clinical directors. Five Arrows Capital Partners supported this acquisition with partner Michael Langer noted. |
Acquisition of EBS Healthcare March 15, 2021 | Acquisition of EBS Healthcare, a Pennsylvania-based therapeutic and behavioral company, expanding Stepping Stones' national footprint. This deal was supported by Five Arrows Capital Partners. Leadership involved includes Tim Murphy (CEO of Stepping Stones Group) and Michael Langer (Partner at Five Arrows Capital Partners). |
Executives
| Name | Background |
|---|---|
Nicholas Tomczak Senior Vice President of Operations and Post Merger Integration | Nicholas Tomczak has been with The Stepping Stones Group for over 15 years. He holds a BS degree from Western Michigan University - Haworth College of Business. His role focuses on operations and integrating acquisitions post-merger, contributing significantly to the company's growth from about 80 employees to over 3,000. His long tenure indicates deep operational expertise and leadership in scaling the company. |
Tim Ulmer, Ph.D. Senior Vice President of Growth | Tim Ulmer has been with The Stepping Stones Group for about 8 months as of early 2026. He holds a Ph.D. in School Psychology from the University of Northern Colorado. Prior to this role, he served as Executive Director at HealthCare Support for over 7 years, Vice President of Business Development at ChanceLight Behavioral Health & Education, and Director of Achievement at EdisonLearning. His experience spans behavioral health, education, and business development, positioning him well for driving growth initiatives. |
Robert Parsons Senior Vice President, Corporate Initiatives and Post Merger Integration | Robert Parsons has been with The Stepping Stones Group for nearly 4 years. He holds an MBA from Boston College. Before joining, he worked at Commonwealth Care Alliance as Senior Vice President of Strategic Initiatives, Citizens Bank as Senior Vice President, and Blue Cross Blue Shield of Massachusetts in enterprise program management. His background in strategic initiatives and corporate integration supports his current role. |
Summer A.G. Johnson Senior Vice President, Employee Development and Operations | Summer A.G. Johnson has been with The Stepping Stones Group for 6 years. Previously, she held leadership roles including Vice President Client Services at Cobb Pediatric Therapy Services and Vice President at Progressus Therapy. Her experience is rooted in employee development and operational leadership within therapeutic service organizations. |
Jen Dunning Senior Director of Finance | Jen Dunning has been with The Stepping Stones Group for 11 months. She holds a BA from Boston College. Her prior roles include Director of Financial Planning and Analysis at MorphoSys, Executive Director of Financial Planning and Analysis at Steward Health Care, and Director of North America Finance at Helen of Troy. She brings extensive financial leadership and planning expertise. |
Michael McGreal Chief Corporate Development Officer | Michael McGreal joined The Stepping Stones Group as Chief Corporate Development Officer in 2018. He has over 20 years of experience in healthcare industry leadership and advisory roles. Previously, he was COO at Ieso Digital Health and an advisor at Workit Health. He holds an MBA from Babson College - Franklin W. Olin Graduate School of Business. His expertise lies in corporate development, mergers, and strategic growth. |
Leonard Green & Partners